IL DONG PHARMACEUTICAL CO., LTD. Q3 consolidated operating profit KRW 7.1 billion, up 5.7% year on year
IAI summary · Not investment advice
Q3 consolidated revenue was KRW 151.0 billion, and operating profit was KRW 7.1 billion, up 5.7% from a year earlier.
Operating profit · current quarter
KRW 7.1 billion
Key facts
- Basis
- Consolidated
- Revenue (current quarter)
- KRW 151.0 billion
- Revenue (previous quarter)
- KRW 147.9 billion
- Revenue (prior-year quarter)
- KRW 145.5 billion
- Revenue change vs. previous quarter
- 2.1%
- Revenue change vs. prior-year quarter
- 3.8%
- Revenue (year to date)
- KRW 440.8 billion
- Operating profit (previous quarter)
- KRW 2.0 billion
- Operating profit (prior-year quarter)
- KRW 6.8 billion
- Operating profit change vs. previous quarter
- 260.8%
- Operating profit change vs. prior-year quarter
- 5.7%
- Operating profit (year to date)
- KRW 18.4 billion
- Net income (current quarter)
- KRW -4.4 billion
- Net income (previous quarter)
- KRW 5.1 billion
- Net income (prior-year quarter)
- KRW 21.5 billion
- Net income change vs. previous quarter
- Swung to loss
- Net income change vs. prior-year quarter
- Swung to loss
- Net income (year to date)
- KRW 8.1 billion
- Net income attributable to owners (current quarter)
- KRW -3.9 billion
Commentary
AI commentary · Not investment advice
What happened
Ildong Pharmaceutical released its preliminary consolidated third-quarter results through a fair disclosure. Revenue was KRW 151.0 billion, operating profit was KRW 7.1 billion, and net income was a loss of KRW 4.4 billion. Net income attributable to owners of the parent was a loss of KRW 3.9 billion. Year-to-date revenue was KRW 440.8 billion, operating profit KRW 18.4 billion, and net income KRW 8.1 billion.
In the company's terms
Against the prior quarter (revenue KRW 147.9 billion, operating profit KRW 2.0 billion, net income KRW 5.1 billion), revenue rose 2.1% and operating profit rose 260.8%. Net income swung from a profit to a loss. Against the same quarter a year earlier (revenue KRW 145.5 billion, operating profit KRW 6.8 billion, net income KRW 21.5 billion), revenue rose 3.8% and operating profit rose 5.7%, while net income turned to a loss.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist